Recall risk due to product defects, adverse effects and foreign-material contamination
First written in FY2016. 19 of 21 entries say "Restated". Latest entry: FY2026.
Rohto Pharmaceutical moved to the "Worse" side of this theme in 2026, 3 years after the typical company in this theme (2023).
The whole theme swung hardest in 2025: 13 of 36 companies on the "Worse" side.
4 other companies' latest entry also says "Reframed".
- FY2026ReframedAnnual report
「If product defects, unexpected adverse effects, foreign-material contamination, inappropriate labeling or advertising, quality-control problems or other issues arise in some of the products and services, this could lead to the discontinuation of sales, product recalls, administrative action, claims for damages and damage to brand value.」
The Company has reorganized the previous recall risks arising from defects, adverse effects and foreign-material contamination to include labeling and advertising, inappropriate expressions, quality control and administrative action as quality and product-safety risks. - FY2024-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2024-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2024-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2023-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2021-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2020-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2020-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2019-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2019-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2019-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2018-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2018-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2018-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no material changes in unusual fluctuations in the Company's financial position, operating results or cash flows, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes to the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2017RestatedAnnual report
「If some of the Group's products are subject to product defects, unexpected side effects, foreign-material contamination or other issues, resulting in situations such as the discontinuation of sales or product recalls, this could affect business performance and financial condition.」
The Company has reconfirmed the risks of sales discontinuation and recalls due to product defects, adverse effects and foreign-material contamination. - FY2016First statedAnnual report
「If some of the Group's products are subject to product defects, unexpected side effects, foreign-material contamination or other issues, resulting in situations such as the discontinuation of sales or product recalls, this could affect business performance and financial condition.」
The Company identifies the discontinuation of sales and product recalls due to product defects, unexpected adverse effects and foreign-material contamination as risks that could affect operating results and financial condition.